Table 2. Selected In-Hospital Interventions And Drug Treatments: South African Cohort According To Discharge Diagnosis And Overall, And Complete Access Study Overall.
| South Africa | ACCESS | |||
| In-hospital interventions and drug treatments | NSTE-ACS (n = 362) | STEMI (n = 253) | All (n = 615) | All (n = 11731) |
| Thrombolytics | 20 (5.5) | 91 (36) | 111 (18) | 2127 (18.1) |
| Angiography | 344 (95) | 228 (90.1) | 572 (93) | 6787 (57.8) |
| PCI | 179 (49.4) | 151 (59.7) | 330 (53.7) | 4141 (35.2) |
| CABG | 70 (19.3) | 20 (7.9) | 90 (14.6) | 668 (5.6) |
| Stent (% of PCI) | 172 (96.1) | 139 (92.1) | 311 (94.2) | 3900 (33.2) |
| Drug-eluting stent (% of total stent usage) | 108 (62.8) | 72 (51.8) | 180 (57.9) | 1713 (43.9) |
| Aspirin | 331 (91.4) | 247 (97.6) | 578 (94) | 10920 (93) |
| Unfractionated heparin | 131 (36.2) | 113 (44.7) | 244 (39.7) | 4636 (39.5) |
| LMWH | 264 (72.9) | 188 (74.3) | 452 (73.5) | (7144) (60.8) |
PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; LMWH: low-molecular weight heparin. Unless otherwise indicated, results are reported as number (percent); ACCESS includes South Africa.